Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Updated for 2026 with CMS-0057-F rule, Medicare GLP-1 Bridge program, MFN pricing deals, oral Wegovy approval, and AHIP reform pledges.
Also Referenced As TH9507 GHRH(1-44) Analogue Trans-3-Hexenoyl-GHRH(1-44)NH Egrifta (clinical brand name) Sourced through an established North American supply partner that reviews manufacturing facilities onsite and works only with those aligned with GMP practices
and Garg et al
(Emilio Parra Doiztua/Bloomberg)One of the largest healthcare ETFs in the U.S
Semaglutide can still produce significant weight loss in this population, but the timeline may be extended, and the magnitude may be somewhat reduced compared to premenopausal women
US$ 21.92
US$ 22.86
US$ 24.96
US$ 26.98
US$ 25.67
US$ 27.78
US$ 21.97
US$ 22.85
US$ 26.80
